News
1 minute read

MBHB Partner Kevin Noonan Authors BioPharm-International Article Entitled, "Patenting Prospects For Cell-Based Therapies”

Kevin E. Noonan, Ph.D.August 18, 2019 - August 18, 2019

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan authored an article entitled, “Patenting Prospects for Cell-Based Therapies” that appears in the September 15, 2017online edition of BioPharm-International. Treatment using cell-based therapies involves significant investment and, therefore, can be expected to have concomitantly significant costs to patients and their insurers. View the article